期刊文献+

新疆维、哈族冠心病患者降低低密度脂蛋白-胆固醇疗效的比较

Comparison of therapeutic effect lowering low density lipoprotein cholesterol in Uygur and Kazak nationality patients with coronary heart disease from Xinjiang
下载PDF
导出
摘要 目的:对比明确诊断为冠心病的维、哈族患者治疗前后的低密度脂蛋白胆固醇(LDL-C)水平,进一步指导临床治疗。方法:对首次入院行冠脉造影检查并明确诊断为冠心病的维族(191例)、哈族(184例)患者测定其LDL-C浓度,并给予冠心病二级预防治疗8-12个月,住院后再次测定LDL-C浓度,并行统计学比较分析。结果:治疗后维、哈两族冠心病患者 LDL-C水平均有显著降低,且维族冠心病患者较哈族LDL-C [(2.21±0.17)mmol/L比(2.74±0.13)mmol/L]水平降低得更显著(t=3.141,P<0.01)。结论:维族冠心病患者低密度脂蛋白水平降脂的疗效显著好于哈族。 Objective:To compare the level of low density lipoprotein cholesterol (LDL-C)before and after treatment between Uygur and Kazak nationality patients diagnosed as coronary heart disease (CHD).Methods:A total of 191 Uygur nationality patients and 184 Kazak nationality patients,who received coronary angiography and were diagnosed as CHD first time, and received measurement of LDL-C concentration.They received CHD secondary preventive treatment for 8-12 months,LDL-C concentration was measured again after treatment,and it's compared and analyzed between two nationalities.Results:After treatment,there were significant reductions in levels of total cholesterol (TC)and LDL-C in Uygur and Kazak nationality CHD patients.Compared with Kazak nationality patients,there were significant reductions in levels of LDL-C [(2.74±0.13)mmol/L vs.(2.21±0.17)mmol/L]in Uygur nationality CHD patients (t=3.141,P〈0.01).Conclusion:Effect lowering in Uygur nationality patients with coronary heart disease ,especially low density lipoprotein cholesterol is better than that of Kazak nationality.
出处 《心血管康复医学杂志》 CAS 2014年第3期292-294,共3页 Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词 冠状动脉疾病 脂蛋白类 LDL 新疆 Coronary artery disease Lipoproteins, LDL Xinjiang
  • 相关文献

参考文献4

二级参考文献21

  • 1吴桂贤,吴兆苏,王薇,刘静,孙佳艺,刘军,赵冬.1992—2002年北京一组队列人群心血管病危险因素变化趋势研究[J].中华心血管病杂志,2005,33(8):748-753. 被引量:53
  • 2中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5222
  • 3武阳丰,赵冬,周北凡,王薇,李贤,刘静,李莹,孙佳艺,赵连成,吴兆苏,诸骏仁.中国成人血脂异常诊断和危险分层方案的研究[J].中华心血管病杂志,2007,35(5):428-433. 被引量:175
  • 4张小茜,周富荣,石济民.高效液相色谱法测血脂康胶囊及红曲中洛伐他汀的含量[J].中国中药杂志,1997,22(4):222-224. 被引量:33
  • 5World Health Organization.Multination monitoring of treads and determinants in cardiovascular disease (MONICA project) and manual of operation.Cardiovascular Disease Unit,Geneva,1993.
  • 6Wilson Peter WF,Agostino RBD,Levy D,et al.Prediction of coronary heart disease using risk factor categories (Framingham),Circulation,1998,97:1837-1847.
  • 7National Cholesterol Education Program (NCEP) Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ).Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ) final report.Circulation,2002,106:3143-3421.
  • 8Leppala JM,Virtamo J,Fogelholm R,et al.Different risk factors for different stroke subtypes:association of blood pressure,cholesterol,and antioxidants.Stroke,1999,30:2535-2540.
  • 9Zhang X,Patel A,Horibe H,et al.Cholesterol,coronary heart disease,and stroke in the Asia Pacific region.Int J Epidemiol,2003,32:563-572.
  • 10Kuulasmaa K,Pedoe TH,Dobson A,et al.Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations.Lancet,2000,355:675-687.

共引文献254

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部